ASM vs IPX

ASM presents a paradoxical profile with a stable Piotroski F-Score of 4/9 and exceptional balance sheet health, yet it trades at a significant premium to its Graham Number ($2.35) and Intrinsic Value ($5.02). While YoY earnings growth is explosive (82.90%) and margins are robust, the company has failed to beat earnings estimates in the last four consecutive quarters with a severe average surprise of -30.56%. The stark contrast between the 'Strong Buy' analyst consensus and the bearish technical trend/poor earnings track record suggests a high-risk growth play dependent on future production targets rather than current execution.

IPX exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor operational health. While the company maintains a strong liquidity position with a Current Ratio of 4.03 and very low debt (D/E 0.04), it is currently plagued by severe profitability issues, including an ROE of -50.42% and a negative forward P/E. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual deterministic data, which shows a bearish technical trend (0/100) and a sharp 6-month price decline of 41.3%.